Double maintains 1 strategies that include ALT - Altimmune, Inc.
SeekingAlpha
Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway. Click for my ALT stock update.
Finnhub
Altimmune Inc: * ALTIMMUNE INC - PHASE 2 AUD TRIAL FOR PEMVIDUTIDE EXPECTEDIN Q22025Further company coverage: ...
Finnhub
Altimmune said on Thursdaythat it plans to test its lead experimental obesity drug,pemvidutide, to potentially treat alcohol use disorder andalcohol-associated liver disease. ...
Yahoo
Program to Feature Presentations from Renowned KOLs in Obesity, MASH and Two Additional Indications for Pemvidutide following recent IND Clearances by FDAGAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will host a virtual R&D Day on Thursday, March 13, 2025 beginning at 12:00 pm Eastern Time. The event will include presentations from renowned Key Opinion Leaders (KOLs) in obesity, MASH
Yahoo
GAITHERSBURG, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Leerink Global Healthcare Conference. Details are as follows: Conference:Leerink Global Healthcare Conference Date/Time:Monday, March 10, 2025, at 3:40 p.m. EST The session will be webcast and can be accessed by visiting the Events section of the Altimmune webs
SeekingAlpha
Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market impact. Read more on ALT stock here.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTP | 0.01% | $108.59M | 0.07% |
BSMR | 0.06% | $232.31M | 0.18% |
IBMO | -0.14% | $505.83M | 0.18% |
CLOI | 0.15% | $1.02B | 0.4% |
UDN | -0.17% | $69.33M | 0.78% |
COM | -0.18% | $241.04M | 0.72% |
SUB | 0.32% | $8.75B | 0.07% |
XHLF | -0.38% | $1.06B | 0.03% |
MMIN | -0.42% | $471.66M | 0.3% |
IBMN | -0.67% | $473.20M | 0.18% |
KBA | -0.73% | $198.48M | 0.56% |
KMLM | -0.76% | $222.40M | 0.9% |
BILS | 0.79% | $3.66B | 0.1356% |
CCOR | -1.00% | $64.35M | 1.18% |
BSMW | 1.09% | $100.61M | 0.18% |
DFNM | 1.15% | $1.50B | 0.17% |
XONE | -1.21% | $628.76M | 0.03% |
AGZD | 1.24% | $136.29M | 0.23% |
PPLT | 1.39% | $1.06B | 0.6% |
CNYA | -1.42% | $219.11M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 52.35% | $5.33B | 0.35% |
PBE | 49.71% | $233.11M | 0.58% |
IBB | 47.71% | $5.92B | 0.45% |
PTH | 45.59% | $110.42M | 0.6% |
GNOM | 44.87% | $53.29M | 0.5% |
BBH | 43.17% | $368.79M | 0.35% |
FBT | 42.56% | $1.08B | 0.56% |
IWC | 42.50% | $810.14M | 0.6% |
IWO | 41.30% | $10.88B | 0.24% |
QQQJ | 41.23% | $594.32M | 0.15% |
VBK | 40.96% | $17.51B | 0.07% |
ISCG | 40.88% | $654.50M | 0.06% |
VXF | 40.69% | $20.19B | 0.05% |
CLOU | 40.29% | $311.54M | 0.68% |
XSW | 40.25% | $464.74M | 0.35% |
TMSL | 39.78% | $654.90M | 0.55% |
SECT | 39.77% | $1.83B | 0.78% |
KJUL | 39.64% | $155.38M | 0.79% |
IWM | 39.57% | $64.21B | 0.19% |
IMCG | 39.54% | $2.49B | 0.06% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SDGR | 41.68% | $1.44B | -25.03% | 0.00% |
CLDX | 40.43% | $1.20B | -56.41% | 0.00% |
VKTX | 40.03% | $2.71B | -69.62% | 0.00% |
DNLI | 39.73% | $1.97B | -33.88% | 0.00% |
CRNX | 39.37% | $3.12B | -27.92% | 0.00% |
TGTX | 39.34% | $6.19B | +166.96% | 0.00% |
BTCT | 37.98% | $20.20M | +17.54% | 0.00% |
STOK | 37.74% | $359.62M | -50.70% | 0.00% |
RCKT | 37.64% | $711.22M | -75.04% | 0.00% |
ARWR | 36.69% | $1.75B | -54.89% | 0.00% |
COGT | 36.68% | $681.96M | -13.19% | 0.00% |
KOD | 36.28% | $147.61M | -36.97% | 0.00% |
PRTA | 36.15% | $666.11M | -52.68% | 0.00% |
MSA | 35.95% | $5.76B | -23.17% | 1.40% |
CELC | 35.10% | $375.38M | -51.35% | 0.00% |
OLO | 35.02% | $1.00B | +12.48% | 0.00% |
XNCR | 34.83% | $749.71M | -51.46% | 0.00% |
BKE | 34.83% | $1.95B | -<0.01% | 3.63% |
NXTC | 34.82% | $13.45M | -79.21% | 0.00% |
SLAB | 34.23% | $3.66B | -20.71% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -14.63% | $23.69B | +24.42% | 1.08% |
PHG | -10.57% | $23.50B | +32.47% | 0.00% |
TCTM | -10.07% | $3.39M | -83.19% | 0.00% |
THS | -9.57% | $1.36B | -30.00% | 0.00% |
NEUE | -9.10% | $58.51M | +7.28% | 0.00% |
GFI | -8.59% | $19.77B | +38.50% | 2.46% |
STNG | -8.23% | $1.88B | -48.34% | 4.25% |
STG | -7.81% | $28.45M | -43.90% | 0.00% |
BG | -7.57% | $10.24B | -25.29% | 3.53% |
CPB | -6.69% | $11.90B | -10.61% | 3.74% |
AEP | -6.40% | $58.35B | +29.22% | 3.34% |
CQP | -6.00% | $31.97B | +33.68% | 4.87% |
LITB | -5.79% | $36.77M | -56.14% | 0.00% |
VHC | -5.44% | $31.32M | +18.43% | 0.00% |
HAIN | -5.43% | $374.52M | -44.59% | 0.00% |
TEF | -5.41% | $26.30B | +6.15% | 6.71% |
NGL | -5.40% | $599.34M | -21.72% | 0.00% |
BF.B | -5.30% | $16.04B | -33.48% | 2.61% |
VOD | -5.04% | $23.40B | +6.60% | 7.71% |
BNED | -4.99% | $357.56M | -83.95% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NEE | -0.02% | $145.82B | +11.85% | 2.97% |
VALE | -0.07% | $42.60B | -13.73% | 0.00% |
TRMD | 0.07% | $1.61B | -53.16% | 39.46% |
ZTO | -0.10% | $11.75B | -7.51% | 4.87% |
EC | 0.11% | $21.46B | -13.79% | 14.98% |
INSP | -0.12% | $4.74B | -24.02% | 0.00% |
PLG | -0.15% | $127.39M | -6.66% | 0.00% |
BBW | 0.17% | $499.56M | +25.40% | 2.21% |
AVDL | -0.21% | $756.61M | -53.00% | 0.00% |
ULS | -0.21% | $11.29B | +101.43% | 0.90% |
IEP | 0.22% | $4.74B | -46.61% | 33.65% |
VIRT | -0.25% | $3.30B | +81.18% | 2.53% |
DBD | -0.26% | $1.65B | +27.72% | 0.00% |
CI | -0.29% | $89.19B | -9.64% | 1.73% |
TKO | 0.30% | $12.46B | +77.31% | 0.25% |
DUK | 0.32% | $94.77B | +26.96% | 3.42% |
SJM | 0.33% | $12.60B | -5.07% | 3.61% |
AGL | 0.34% | $1.79B | -25.86% | 0.00% |
EL | 0.35% | $23.74B | -56.59% | 3.02% |
KEP | -0.40% | $9.51B | -9.52% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -27.98% | $404.97M | 1.43% |
VIXY | -25.72% | $195.31M | 0.85% |
TAIL | -21.98% | $86.92M | 0.59% |
USCI | -11.56% | $236.09M | 1.07% |
TPMN | -9.68% | $33.51M | 0.65% |
DBE | -8.23% | $54.58M | 0.77% |
CTA | -7.56% | $963.19M | 0.76% |
PDBC | -7.56% | $4.82B | 0.59% |
DBA | -7.19% | $822.16M | 0.93% |
BCD | -7.18% | $249.09M | 0.3% |
FTGC | -7.08% | $2.50B | 1.02% |
CGSM | -7.00% | $636.53M | 0.25% |
COMT | -6.95% | $674.22M | 0.48% |
USL | -6.45% | $46.60M | 0.85% |
SOYB | -6.36% | $25.81M | 0.22% |
BNO | -6.32% | $95.40M | 1% |
CMDY | -6.27% | $306.57M | 0.28% |
BCI | -5.96% | $1.43B | 0.26% |
DBC | -5.94% | $1.32B | 0.87% |
UGA | -5.77% | $88.11M | 0.97% |
Current Value
$4.951 Year Return
Current Value
$4.951 Year Return